Latest Resources

AFSA’s comments on ARIPO’s response to civil society: Draft legal framework for plant...

At the 2013 November meeting of the Administrative Council and Council of Ministers of ARIPO countries held in Kampala, Uganda, several documents on the proposed legal framework for Plant Variety Protection were distributed. Also circulated was a Matrix1 containing ARIPO’s responses to a detailed submission by civil society organisations (CSOs) dated 6th November 2013. In […]

Synthetic Biology in Africa: Recent Developments

By Gareth Jones and Mariam Mayet The focus of this paper is the emerging field of synthetic biology, in particular its implications for the African continent. Synthetic biology combines a number of scientific disciplines and is generally understood to involve the deliberate design of biological systems, using standardised components that have been created in a […]

A good neighbour? South Africa forcing GM maize onto African markets and policy makers

Since the beginning of 2010, South Africa’s Executive Council responsible for GMO permit approvals has granted export permits for almost 300,000 Metric Tons (MT) of GM maize to be exported to Kenya, Mozambique, and Swaziland collectively, and 35,000 MT of GM soybean to Mozambique.1 Despite South Africa being Africa’s largest producer of maize, and a […]

GM Sugarcane: A long way from commercialisation?

Despite the best part of a decade of research and field trials, genetically modified sugar cane in South Africa remains a long way from commercial cultivation. Numerous research projects are currently underway at a number of publicly and privately funded research bodies, most of which are concentrating on increased sucrose and biomass content. Late last […]

Mozambique – GMO Legislation

The proposed biosafety regulatory regime (hereafter referred to as the “draft biosafety law” or “biosafety law”) of the Republic of Mozambique consists of a draft Decree of Council of Ministers, containing the biosafety regulation and 2 draft technical guidelines for risk evaluation as well as public awareness and participation in biosafety and biotechnology related issues. […]